As of 4:04pm ET
| -0.03 / -0.06%|
The 26 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 52.55, with a high estimate of 59.05 and a low estimate of 39.54. The median estimate represents a +13.09% increase from the last price of 46.47.
The current consensus among 29 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.